These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4404106)

  • 21. [Transmission of measles during four outbreaks in a partially vaccinated population].
    Grilli G; Cimini D; Morbidelli L; Vacca F
    Minerva Pediatr; 1993; 45(1-2):21-8. PubMed ID: 8316159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
    Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
    Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications of IFN-alpha, TNF-alpha and IFN-gamma serum levels in children vaccinated against measles.
    Liguori G; Tolone C; D'Avanzo M; Corbisiero G; Di Benedetto R; Del Prete U
    Ann Ig; 1998; 10(5-6):303-6. PubMed ID: 10052194
    [No Abstract]   [Full Text] [Related]  

  • 25. [Trials of vaccination against measles with live and attenuated virus].
    Albano A; De Donato S; Nodari R; Criscuolo A
    G Mal Infett Parassit; 1967 Oct; 19(10):631-8. PubMed ID: 5611500
    [No Abstract]   [Full Text] [Related]  

  • 26. [The clinical evaluation and immunological response of a new measles vaccine].
    Moretti P; Branciaroli A; Di Battista S; Di Filippo A; Di Pietro M; Calafiore P; Di Battista C
    Minerva Pediatr; 1993 Mar; 45(3):83-6. PubMed ID: 8341231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine.
    Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077
    [No Abstract]   [Full Text] [Related]  

  • 28. [Measles vaccination using Schwarz strain: clinical, serologic and electroencephalographic study].
    Fourrier A; Beaussart M; Camier P; Lacombe A
    Pediatrie; 1969; 24(1):97-8. PubMed ID: 5385115
    [No Abstract]   [Full Text] [Related]  

  • 29. Two mechanisms of interferon production by leukocytes from immunized animals.
    Trubina LM; Yakovenko ZF; Zakharchenko EM; Lychkovskaya EV
    Acta Virol; 1975 Apr; 19(2):116-20. PubMed ID: 239556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
    Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F
    J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on measles in Thailand. V. Protection against a measles outbreak by previous vaccination in an isolated institution.
    Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S; Okuno Y
    Biken J; 1971 Dec; 14(4):413-7. PubMed ID: 5149999
    [No Abstract]   [Full Text] [Related]  

  • 35. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal age for vaccinating Zimbabwean children against measles. 1. Maternal and transplacentally transmitted measles antibodies in infancy.
    Mhere OT; Mhlanga GE; Spencer HR
    Cent Afr J Med; 1984 Oct; 30(10):187-9. PubMed ID: 6518490
    [No Abstract]   [Full Text] [Related]  

  • 37. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
    Böttiger M; Heller L; Kamensky P; Svanberg B
    Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
    [No Abstract]   [Full Text] [Related]  

  • 39. [The role of vaccinated individuals in measles morbidity during the vaccination period].
    Deshevoĭ SE; Makarova NT; Petrova VN; Malykhina RM
    Tr Inst Im Pastera; 1983; 61():158-64. PubMed ID: 6235629
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vaccination against measles].
    Ek E
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):135-7. PubMed ID: 5539605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.